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Blood pressure telemonitoring (BPT) is a telemedicine strategy that uses a patient’s
self-measured blood pressure (BP) and transmits this information to healthcare providers,
typically over the internet. BPT has been shown to improve BP control compared
to usual care without remote monitoring. Traditionally, a cuff-based monitor with data
communication capabilities has been used for BPT; however, cuff-based measurements
are inconvenient and cause discomfort, which has prevented the widespread use of
cuff-based monitors for BPT. The development of new technologies which allow for
remote BP monitoring without the use of a cuff may aid in more extensive adoption
of BPT. This would enhance patient autonomy while providing physicians with a more
complete picture of their patient’s BP profile, potentially leading to improved BP control
and better long-term clinical outcomes. This mini-review article aims to: (1) describe the
fundamentals of current techniques in cuff-less BPmeasurement; (2) present examples of
commercially available cuff-less technologies for BPT; (3) outline challenges with current
methodologies; and (4) describe potential future directions in cuff-less BPT development.
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INTRODUCTION
Hypertension has been well established as a leading risk factor for cardiovascular morbidity and
mortality (1). The lifetime risk of developing stage two hypertension, ≥140 mmHg systolic or ≥90
mmHg diastolic based on the 2017 American Heart Association guidelines for hypertension, is
nearly 90% (2). Importantly, intensive blood pressure (BP) control has been shown to significantly
reduce cardiovascular morbidity and all-causemortality associated with hypertension (3). For these
reasons, frequent measurement of BP is recommended in patients with hypertension (4, 5).
BP telemonitoring (BPT) has recently emerged as a promising e-health treatment in
hypertension management. BPT involves self-measurement of BP and transmission of the data
to the patient’s physician, who then can adjust medical therapy accordingly. BPT allows for greater
patient autonomy, convenience, and perceived control over management of their chronic condition
(6). Most importantly, several large meta-analyses have demonstrated that home BPTmay be more
efficacious at lowering both systolic and diastolic BP while normalizing BP in a larger proportion
of patients vs. traditional office-based care (7–9). The effect of BPT is largely dependent on co-
interventions such as medication titration by health care providers, stressing the importance of the
data transmission component of BPT (10).
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Traditionally, BPT is accomplished using an automated
upper-arm cuff BP monitor with data transmission capabilities
(11). However, these cuff-based methods have proven to be a
barrier to widespread use of BPT due to discomfort associated
with measurements and the rather bulky equipment that is
needed (12). A more simple and user-friendly BP measurement
device would enablemore widespread use of BPT in hypertension
management (13).
Several BP measuring devices have recently become
commercially available that can measure BP without a cuff,
giving patients a more user-friendly alternative to the traditional
cuff (Table 1). This article aims to: (1) describe the fundamentals
of current techniques in cuff-less BP measurement; (2) present
examples of commercially available cuff-less technologies for
BPT; (3) outline challenges with current methodologies; and (4)
describe potential future directions in cuff-less BPT development.
Cuff-Less BP Measurement Solutions
Smartphone Applications
A smartphone is a mobile phone that performs many of the
functions of a computer, typically having a touchscreen interface,
internet access, and an operating system capable of running
downloaded apps. Seventy-seven percent of Americans currently
own a smartphone, and smartphones offer a great potential to
expand BPT use if their sensors can be manipulated to measure
BP (14). The application of mobile devices in healthcare is often
referred to as m-health (15).
Smart phone applications that help users track BP values
longitudinally (measured with another device) have been around
for some time, but applications that actually enable the
smartphone itself to measure BP are relatively novel. A 2015
survey of mobile phone applications developed for hypertension
management found that seven applications claimed to measure
BP; the public’s interest in these applications is demonstrated by
the fact that some of these applications had been downloaded
almost onemillion times in 2015 (16). Themanufacturers of these
applications typically do not disclose how the measurements
are performed, and the accuracy of these measurements is
currently mostly unknown. A formal validation study on one
particular iOS application, the Instant Blood Pressure app,
revealed poor accuracy of BP measurements (17). Researchers
found mean absolute differences of 12.4 mmHg for systolic BP
and 10.1 mmHg for diastolic BP between the Instant Blood
Pressure application and a reference device. This correlated
to approximately four out of five hypertensive individuals
being falsely classified as normotensive. More recently, Samsung
announced a collaboration with the University of California, San
Francisco, to develop the My BP Lab application that utilizes a
built-in optical sensor in the Galaxy S9 mobile phone to measure
BP (Figure 1A) (18). The My BP Lab application measures BP
through measurements of pulse transit time (PTT). PTT refers
to the time required for the arterial pressure wave to travel
from the left ventricle to a distal arterial site (Figure 1B). PTT
is inversely related to blood pressure and dependent on arterial
compliance, arterial wall thickness, arterial radius, and blood
density (19). The inter-individual differences in these parameters
necessitate initial calibration of PTT-based BP measurements
to a cuff-based BP monitor (19). PTT is typically calculated
using electrocardiogram and photoplethysmography sensors to
measure ventricular ejection and peripheral arterial pulse arrival
time, respectively (20).
Wearables
Wearable technology is a blanket term for electronics that
can be worn on the body, either as an accessory or as part
of material used in clothing. One of the major features of
wearable technology is its ability to connect to the internet
through a smartphone, computer or tablet, enabling data
to be exchanged between a network and the device. There
are many types of wearable technology, but some of the
most popular devices are activity trackers and smartwatches.
Smartwatches are becoming increasingly popular, and 15% of
the adult US population is expected to own a smartwatch
in 2019 (21).
Several smartwatches that measure BP have recently been
introduced. Most of these wearables measure BP through PTT
from a pulse wave measurement at the wrist. The Heartisans
Blood Pressure Watch (Heartisans, Hong Kong, Hong Kong)
is such a smartwatch that utilizes electrocardiography and
photoplethysmography to measure PTT and estimate BP. The
Heartisans watch requires a motionless 20-s scan with the device
held at heart level for measurements and provides systolic and
diastolic BP readings. Calibration with a validated cuff-type
BP device is required prior to standalone use. Measurements
are synchronized to a phone application developed by the
manufacturer through Bluetooth. Despite its availability on the
market, the Heartisans Watch has not undergone a formal
validation study.
Another method to obtain BP measurements from the
wrist with a smartwatch is through arterial tonometry
(Figure 2). Arterial tonometry utilizes the concept of arterial
wall applanation to measure the arterial BP waveform. The BPro
device (HealthSTATS Technologies, London, United Kingdom)
is a smartwatch based on tonometry. The tonometer’s force
transducer is integrated into the wrist strap of the watch
and compresses the tissue and radial artery enough to cause
applanation, while a monitor displays readings to the patient
and wirelessly transmits data to a secure web portal that can
be accessed by the clinician. The BPro is marketed to Family
and General Practitioners as an alternative to conventional
ambulatory cuff BP monitors and comparatively allows for
continuous 24-h waveform analysis of BP vs. traditional
20-min interval snapshot measurements. Calibration to the
brachial artery BP is required using a validated upper arm
cuff device prior to use. To avoid a loss of coupling to the
radial artery during measurement, the BPro requires fixation
with adhesive tape prior to the 24-h measurement period
by the prescribing physician. The BPro has been validated
in a non-ambulatory study following the Association for the
Advancement of Medical Instrumentation (AAMI) standards
and the European Society of Hypertension (ESH) protocol
(22). The AAMI standard requires a mean BP difference
of ≤5 mmHg with a standard deviation of ≤8 mmHg vs.
auscultatory reference measurement, whereas the ESH protocol
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TABLE 1 | Cuff-less devices for BP monitoring.
BP
measurement
method
Calibration
needs
Vital sign
measurements
provided
Duration of
measurement
Connectivity Level of
validation
Cost
SMARTPHONE APPLICATIONS
My BP Lab PTT Required with
validated
cuff-based device
before use
SBP, DBP 10 s Users have to consent
to be a part of a
research study on the
app when using it. Data
is shared with
researchers at UCSF
No published
validation
studies
Free to
download
from Google
Play store
Instant
Blood
Pressure
Not
disclosed
Not required SBP, DBP 10 s Data stored on
smartphone local
memory
Did not meet
AAMI
guidelines in
non-
ambulatory
setting (17)
$4.99*
WEARABLES
Heartisans
Watch
PTT Required with
validated
cuff-based device
before first use
SBP, DBP,
HR, HR, EKG,
Pedometer
20 s Connects with
smartphone application
through Bluetooth
No published
validation
studies
$150
BPro Tonometry Required with
validated
cuff-based device
before use
SBP, DBP,
HR, Pulse
Waveform
Continuous
measurement
Data sent to secure
cloud server through
bluetooth
AAMI and
ESH validated
in non-
ambulatory
setting and in
ambulatory
setting
modest
agreement
with
oscillometric
cuff (22, 23)
$2,000
TRICORDERS
Freescan PTT Not required SBP, DBP,
HR, EKG,
Pulse
waveform
10 s Connects with
smartphone through
Bluetooth, data can be
stored on a cloud
server
AAMI
validated in
non-
ambulatory
setting
$225
Bodimetrics PTT Required with
validated
cuff-based device
before use;
recalibration every
three months
SBP, HR,
SpO2, EKG,
Temperature,
Pedometer
20 s Connects with
smartphone through
Bluetooth
Failed to meet
ESH
guidelines in
unconventional
non-
ambulatory
validation
study (25)
$299
SOMNOtouch PTT Required with
validated
cuff-based device
before first use
SBP, DBP,
HR, SpO2,
EKG, Sleep
Patterns
(Actigraph)
Continuous
measurement
Data can be transferred
to a PC via a USB
docking station or sent
to a tablet via
BlueTooth
ESH validated
in non-
ambulatory
setting (28)
$5,200
*Not for sale anymore. BP, blood pressure; PTT, Pulse Transit Time; SBP, systolic blood pressure; DBP, diastolic blood pressure; EKG, electrocardiogram; HR, hearty rate; SpO2, oxygen
saturation; UCSF, University of California, San Francisco; AAMI, Association for the Advancement of Medical Instrumentation; ESH, European Society of Hypertension.
requires that the majority of subjects have investigational BP
readings within ≤5 mmHg of the reference measurement.
While the BPro device met these requirements in a static
environment, the technology is adversely affected by motion
artifact and demonstrated only modest agreement with a
standard automated oscillometric cuff in the ambulatory
setting (23).
Medical “Tricorders”
The idea of a medical tricorder comes from an imaginary
device on the science fiction TV show Star Trek from the
1960s which featured fictional character Dr. Leonard McCoy
using it to instantly diagnose medical conditions (24). In
the present time, a medical tricorder is a handheld portable
device to be used by consumers to self-diagnose medical
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FIGURE 1 | Pulse transit time (PTT) based cuff-less blood pressure measurement. (A) depicts the My BP Lab App that has been developed by Samsung and the
University of California San Francisco. To measure blood pressure, users place their index finger on the optical sensor on the back of the phone. (B) depicts the
underlying principle of PTT based blood pressure measurement. PTT represents the time it takes for a pulse pressure wave to travel from its origin at the heart to a
distal point. Since it is difficult to non-invasively measure a pulse waveform at the heart, the onset of the QRS complex is measured as a surrogate. The arrival of a
pulse pressure wave at the finger or wrist can be measured using a photoplethysmography sensor.
FIGURE 2 | Arterial tonometry based cuff-less blood pressure measurement.
First, a non-invasive arterial tonometer is placed on the skin overlying a
peripheral artery. Then, the sensor applies force to compress the artery against
the underlying bone until the maximum pulse pressure is achieved. At that
point, it can be assumed that the only force acting on the artery is the inward
force of the tonometry sensor (Pt), the outward force of the intravascular blood
pressure (Pa), and the wall tension of the underlying artery (T). The maximum
pulse pressure occurs when the artery is compressed such that the wall
tension force is directed perpendicularly to the tonometry sensor and blood
pressure forces. Directing the wall tension perpendicularly ensures that the
tonometric force measured by the sensor only represents the blood pressure
of the underlying vessel, and any deviation from this axis may introduce
tangential forces and measurement error.
conditions and take basic vital signs measurements. Compared
to wearable devices and mobile phones, medical tricorders
are not “everyday” items already used (i.e., smartphone,
watch); however, their relatively small size and user-
friendliness still make them advantageous relative to cuff
based monitors.
Several manufacturers have recently introduced medical
tricorders that measure BP among other vital signs.
The BodiMetrics Performance Monitor (BodiMetrics
LLC, Manhattan Beach, California, United States) uses
electrocardiogram and photoplethysmograph data to estimate BP
through PTT. The Bodimetrics tricorder obtains measurements
with a 20-s scan of the user’s fingertip at heart level but only
provides systolic BP data. Calibration to a validated cuff-type
device is required prior to standalone use. While the Bodimetrics
Performance Monitor has not been formally validated, it
has been compared to an automated sphygmomanometer in
an unconventional study (25). The observed large spread in
absolute bias vs. an automated sphygmomanometer seems to
indicate that the BodiMetrics Performance Monitor is unlikely
to meet accuracy and precision standards in a formal validation
study. The Bodimetrics tricorder data can be transferred to a
smartphone app through Bluetooth.
Another commercially available tricorder is the FreeScan
Personal Cardiovascular Monitor (Maisense Inc., Zhubei City,
Taiwan). This device estimates BP from PTT as well; however,
the device is unique in that it utilizes a force sensor to capture
the systolic arterial waveform rather than photplethysmography.
This requires the user to physically apply the force sensor directly
to the radial artery for around 10 s for measurements. The
Freescan device has undergone a formal validation according
to the AAMI standards and met the validation criteria (26).
The Freescan tricorder data can be transferred to a smartphone
app and a cloud-based database through Bluetooth and the
internet. Physicians also can sign up to receive warnings
from the cloud-based database when abnormal BP values
are detected.
Lastly, the SOMNOtouch NIBP is a non-traditional medical
tricorder that utilizes PTT data collected in a similar fashion
to the Bodimetrics Performance Monitor. However, it is “non-
traditional” in the sense that it is worn on the wrist, and
photoplethysmography data is collected from a finger clip.
This setup is advantageous because it allows for beat-to-beat
continuous BP measurement, similar to the BPro device, which
may have independent prognostic significance (27). Built-in
Bluetooth allows for easy transfer of data to a PC or mobile
phone. The SOMNOtouch NIBP has been validated according to
the ESH protocol; however, it demonstrated poor agreement at
higher SBP and DBP values (28).
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Current Drawbacks of Cuff-Less BPT
Several limitations pertain to the currently available cuff-less
BP technology.
First, the majority of smartphone applications, wearables,
and tricorders have not undergone a validation protocol, and
as such, their accuracy and precision is unconfirmed. The
devices that have been validated using the static AAMI or ESH
protocol may not have the same accuracy in the ambulatory
setting (23, 28). Importantly, the AAMI and ESH validation
protocols were developed to validate non-invasive cuff-type
BP monitors and are based on an underlying assumption
that the tested device is capable of measuring BP without an
initial calibration reference measurement. Since the calibration
measurement for cuff-less monitors is typically completed just
prior to the conventional, static validation protocol, it is
unlikely that significant variation in BP from this calibration
measurement occurs during a validation series within a subject
(23, 25, 26). In fact, significant variation in BP measurements
(>12 mmHg systolic or >8 mmHg diastolic) from the validated
reference device is an exclusion criterion in the AAMI protocol.
In real life, a cuff-less BP monitor should operate accurately
over a range of pressure after being calibrated at a certain
pressure, but this is not tested when using current protocols. It
is paramount that cuff-less devices are accurate- as inaccurate
measurements may lead to false patient reassurance, unnecessary
health care utilization, ormisguided self-titration of hypertension
medications. Misdiagnosis of hypertension could also lead to
psychological stress and unneeded exposure to adverse side
effects of medication. To highlight the potential scope of such
problems, an error range of just ±5 mmHg could lead to an
estimated 21 million normotensive and 27 million hypertensive
patients being misclassified (29).
Second, the current measurement methods based on PTT
and tonometry are sensitive to motion artifact and loss of signal
upon movement. In several of the aforementioned studies on
cuff-less PTT-based devices, researchers encountered a high
rate of measurement errors and calibration errors (25, 26).
Tonometry-based cuff-less devices need to be tightly coupled to
the underlying artery usually with an adhesive tape to prevent loss
of coupling and loss of measurements (23).
Additionally, the software and data transfer on the back
end of most of the cuff-less BP measurement modalities is
critically underdeveloped. This is a clinically relevant concern,
since frequent BP self-measurement without a co-intervention
from a healthcare provider does not seem to affect BP control
much (10).
Finally, for all of the current cuff-less BPT technologies, it
is presently unclear how the measured values in real life will
relate to clinical or cuff-based home BP measurements. Because
cuff-less methods make it much easier to perform measurements
“on the go,” it is likely that these measurements are substantially
different from resting BP values. Prospective clinical studies
would need to assess how these measurements compare to
conventional BP measurements, and what values or trends are
ultimately associated with adverse outcomes. This would provide
a scientific basis for medication adjustments using cuff-less BPT.
FUTURE DIRECTIONS
To overcome the issues related to extending the use of validation
protocols developed for cuff-based devices to the validation
of cuff-less BP monitors, the Institute of Electrical, and
Electronics Engineers (IEEE) has proposed a validation protocol
specifically for cuff-less BP monitors (30). This validation
protocol requires the same accuracy and precision for cuff-less
monitors as the AAMI standard for cuff-based devices. The
IEEE protocol differs from the AAMI/ESH protocols in that
it includes validation measurements after artificial changes
in BP within a subject after initial calibration to ensure
accuracy over a wide range of BP values. Additionally,
the IEEE protocol includes validation measurements
obtained after a significant time period (weeks to months)
since the initial calibration to investigate time-dependent
calibration integrity.
PTT-based BP measurement is currently an active area of
research, and many groups have developed methods that may
help improve the accuracy of future PTT-based cuff-less BP
measurement devices. For example, BP estimations can be
improved by measuring PTT through plethysmography between
two distal points, rather than from an electrocardiogram and
one distal point (31). To minimize the influence of cardiac pre-
ejection period differences, ballistocardiography (heart sound)
sensors may be useful (32). To reduce the confounding effect
of smooth muscle contraction and relaxation in small arteries
on PTT, there have been attempts to measure PTT in more
central arteries, for example, by using radar (33). Interestingly
a recent study developed a smartphone case that appears to
be able to measure BP accurately using a method combining
photoplethysmography and tonometry (34).
If accurate and user friendly cuff-less smartphone
applications, wearables, or tricorders can be developed in
the future, there are several subsequent steps that would need to
be taken before they can be implemented in clinical BPT practice.
First, safe, secure, and efficient Cloud-based data storage would
need to be developed that is easy to access for healthcare
providers. Then, appropriate prospective clinical studies would
need to assess what values are actually abnormal when using
cuff-less measurements and what values are ultimately associated
with adverse outcomes. If BPT with cuff-less measurement
eventually becomes practical for managing hypertension and
preventing cardiovascular events, development of appropriate
reimbursement structures is needed to allow physicians to
implement its use.
CONCLUSIONS
The availability of simple, accurate, and affordable cuff-less
BP devices has the potential to greatly increase the utilization
of BPT in the management of hypertension. As the field of
connected healthcare continues to expand, further research
is needed to improve the current smartphone, wearable,
and tricorder cuff-less BP technologies. Despite promising
developments and preliminary data, many of the current
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cuff-less BP devices lack proper validation and have limited
practical use due to motion artifact, a lack of proper back-
end databases, and a lack of reimbursement models. Future
validation studies should utilize a cuff-less BP monitor specific
protocol which addresses the potential issues of calibration
procedures and the stability of measurements over time. If
accurate and user friendly cuff-less monitors can be developed,
clinical studies are required to establish the clinical significance
of this type of measurement for BPT in concurrence with
the development of appropriate online databases and proper
reimbursement structures.
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